IGF1 and COVID-19: Hypoxic conditions occurring in acute COVID-19 could induce growth factors such as VEGF, PDGF, EGF and IGF, ultimately potentiating cell proliferation in the vascular bed, and may hold true for those patients with “happy hypoxia” (or local tissue hypoxia) [76, 77].